Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Greenwich LifeSciences, Inc. (GLSI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Revenue          
Operating expenses          
Research and development  1.42.51.70.61.72.10.70.6
General and administrative  0.40.40.70.10.30.30.20.2
    Total operating expenses  1.72.92.40.82.02.40.90.8
    Loss from operations  -1.7-2.9-2.4-0.8-2.0-2.4-0.9-0.8
Interest Income  0.10.10.10.00.00.00.00.0
    Net loss  -1.6-2.8-2.3-0.7-2.0-2.4-0.9-0.7
   
Per share information:          
Net loss per common share, basic  ($0.13)($0.22)($0.18)($0.06)($0.15)($0.18)($0.07)($0.06)
Net loss per common share, diluted  ($0.13)($0.22)($0.18)($0.06)($0.15)($0.18)($0.07)($0.06)
Weighted average common shares outstanding, basic  12.8-0.212.812.913.10.113.012.9
   
Weighted average common shares outstanding, diluted  12.8  12.9    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy